Allianz Asset Management Gmb H Neogenomics Inc Transaction History
Allianz Asset Management Gmb H
- $74.9 Billion
- Q2 2025
A detailed history of Allianz Asset Management Gmb H transactions in Neogenomics Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 345,386 shares of NEO stock, worth $3.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345,386
Previous 303,610
13.76%
Holding current value
$3.55 Million
Previous $2.88 Million
12.39%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding NEO
# of Institutions
308Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$202 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$145 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$76.4 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$70.4 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$52.5 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.29B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...